Showing results (781-790 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|October 23, 2014
A practical guide to value of information analysisEdward C F WilsonPharmacoeconomics|February 15, 2015
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?James Buchanan, Sarah WordsworthPharmacoeconomics|July 12, 2017
The Indonesian EQ-5D-5L Value SetFredrick Dermawan Purba, Joke A M Hunfeld, Aulia Iskandarsyah, et al.Pharmacoeconomics|November 19, 2016
Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the EvidenceRichard De Abreu Lourenco, Marion Haas, Jane Hall, et al.Pharmacoeconomics|June 2, 2018
Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of RifaximinGuy Neff, Woodie ZachryPharmacoeconomics|April 26, 2018
Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalMicah Rose, Jonathan Shepherd, Petra Harris, et al.Pharmacoeconomics|February 23, 2018
Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven CountriesMathieu F Janssen, Gouke J Bonsel, Nan LuoPharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.Pharmacoeconomics|April 16, 2020
Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with RecommendationsMatthew Franklin, James Lomas, Gerry RichardsonPharmacoeconomics|November 1, 2021
Health-Economic Analyses of Diagnostics: Guidance on Design and ReportingSimon van der Pol, Paula Rojas Garcia, Fernando Antoñanzas Villar, et al.Pageof 335